Method: All wounds (surgical excisions, a neuropathic foot ulcer, abdominal and two pressure injury) were managed with the MBGV dressing. The dressing was changed every 2-3 days. For the abdominal wound, the dressing was used to remove devitalized tissue prior to negative pressure wound therapy (NPWT). Additional therapies (e.g. pressure redistribution, compression) were used when indicated to address the underlying cause. Digital images and wound measurements were taken to assess for condition of periwound skin and changes in wound size and amount of devitalized tissue.
Results: Five of the six wounds reduced in size and exhibited a decrease in percentage of devitalized tissue during the use of the dressing. One of the surgical wounds exhibited a reduction of devitalized tissue from 95% to 50% of the wound surface area in 2 days, allowing NPWT to be initiated. The periwound skin remained intact in all cases. Use of the MBGV dressing, in two 90 year old individuals, supported removal of devitalized tissue and enhanced granulation tissue, improvement to pain management where previously they had been unable to tolerate NPWT.
Implications: Results of this case series (removal of devitalized tissue and optimizing moisture balance) indicate the MBGV dressing is a suitable choice for acute and chronic wounds with devitalized tissue and varying levels of wound exudate.